2021-04-28
To open up more entrepreneurial and business opportunities for start-ups and enrich innovative ecosystems for Hong Kong and the Greater Bay Area (GBA), AstraZeneca recently signed a Memorandum of Understanding (MoU) with Hong Kong Science Park and announced a number of new support initiatives.
▲ Group photo of AstraZeneca and Imsight.
Meanwhile, Imsight is honored to be one of the outstanding companies invited to join a town hall meeting in AstraZeneca, offering an opportunity to share the experience of being a start-up in technical developments and foster a chance for cross-collaboration further.
“We are delighted to transit from incubates to graduates in the HKSTP incubation program since 2020 November,” said Chapman Lee, Director of Imsight. “The partnership with AstraZeneca will become an international springboard and facilitate start-ups like Imsight to expose the technology into international markets.”
▲ Dr Clare providing an overview of Imsight’s Core Platform.
“Our AI diagnostic software systems indicate lesions via heatmap or bounding box,” says Dr. Clare Lai, Product Manager, Imsight. “With integrated PACS solutions and short-cut keys, Imsight can optimize hospitals and clinics workflow that truly tailors the needs of doctors.”
